You are viewing an incomplete version of our website. Please click to reload the website as full version.

GFAP antibody (Glial Fibrillary Acidic Protein)

Details for Product anti-GFAP Antibody No. ABIN111958, Supplier: Login to see
Antigen
  • GFAP
  • AI836096
  • cb345
  • etID36982.3
  • gfapl
  • wu:fb34h11
  • wu:fk42c12
  • xx:af506734
  • zgc:110485
Reactivity
Cat (Feline), Human, Pig (Porcine)
578
215
205
97
94
39
26
24
19
16
10
10
6
5
4
4
3
3
2
2
1
1
1
1
1
1
1
1
Host
Mouse
352
304
29
25
4
3
2
Clonality (Clone)
Monoclonal ()
Conjugate
This GFAP antibody is un-conjugated
29
23
19
11
11
11
7
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
1
1
1
1
Application
Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Western Blotting (WB)
507
298
184
182
169
165
77
53
33
21
14
12
11
10
9
8
7
6
5
3
1
1
1
1
1
1
1
1
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen Pellet of Porcine brain cold-stable proteins after depolymerization of microtubules.
Clone GF-01
Isotype IgG2b
Specificity The antibody reacts with GFAP molecules. GFAP is the principal marker of astroglial cells in the central nervous system, it is specifically expressed in satellite cells in peripheral ganglia and in non myelinating Schwann cells in peripheral nerves. The GFAP protein runs on gels at ~55 kDa protein, usually associated with lower Mw bands which are thought to be proteolytic fragments and alternate transcripts from the single gene.
Purification Protein-A Affinity Chromatography
Purity > 95 % (by SDS-PAGE).
Alternative Name GFAP (GFAP Antibody Abstract)
Background Glial Fibrillary Acidic Protein (GFAP) was discovered by Bignami et al. (1972) as a major fibrous protein of multiple sclerosis plaques. It was subsequently found to be a member of the 10 nm or intermediate filament protein family, specifically the intermediate filament protein family Class III, which also includes peripherin, desmin and vimentin. GFAP is heavily, and specifically, expressed in astrocytes and certain other astroglia in the central nervous system, in satellite cells in peripheral ganglia, and in non-myelinating Schwann cells in peripheral nerves. In addition, neural stem cells frequently strongly express GFAP. It is also found in the lens epithelium, Kupffer cells of the liver, in some cells in salivary tumors and has been reported in erythrocytes. Although its function is not fully understood, GFAP protein is probably involved in controlling the shape and movement of astrocytes. The protein probably also plays a significant role in the interactions of astrocytes with other cells, which are required for the formation and maintenance of the insulating layer (myelin) that covers nerve cells. Additionally, GFAP protein may assist in maintaining the protective barrier that allows only certain substances to pass between blood vessels and the brain (blood-brain barrier). In adults, GFAP levels increase as a result of the proliferation of astrocytes that occurs in a response to a variety of physical, chemical and etiological insults, including Alzheimers disease, epilepsy and multiple sclerosis. Antibodies to GFAP are therefore very useful as markers of astrocytic cells and neural stem cells and for distinguishing of neoplasms of astrocytic origin from other neoplasms in the central nervous system. Finally, Alexander's disease was recently shown to be caused by point mutations in protein coding region of the GFAP gene (Brenner et al., 2001). All forms of Alexander disease are characterized by the presence of Rosenthal fibers, which are GFAP containing cytoplasmic inclusions found in astrocytes.Synonyms: Glial Fibrillary Acidic Protein
Gene ID 2670
NCBI Accession NP_001229305
UniProt P14136
Research Area Stem Cells, Cytoskeleton, Glia marker, Cell/Tissue Markers, Neurology
Pathways
Application Notes Western Blotting. Immunoprecipitation. Immunocytochemistry: 5-10 μg/mL. Immunohistochemistry on Paraffin Sections: 10 μg/mL. The antibody strongly stains astrocytes in Human brain tissue sections but it is essentiallynegative on Mouse and Rat tissues.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Concentration 1.0 mg/mL
Buffer Phosphate buffered saline (PBS), pH ~7.4 with 15 mM Sodium Azide as preservative
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing. This product is photosensitive and should be protected from light
Storage 4 °C/-20 °C
Storage Comment Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C longer.
Background publications Brenner, Johnson, Boespflug-Tanguy et al.: "Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease." in: Nature genetics, Vol. 27, Issue 1, pp. 117-20, 2001 (PubMed).

Bignami, Eng, Dahl et al.: "Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence." in: Brain research, Vol. 43, Issue 2, pp. 429-35, 1972 (PubMed).

Lukás, Dráber, Bucek et al.: "Expression of vimentin and glial fibrillary acidic protein in human developing spinal cord." in: The Histochemical journal, Vol. 21, Issue 12, pp. 693-701, 1990 (PubMed).